These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9237156)

  • 1. Serum hepatocyte growth factor/scatter factor levels in small cell lung cancer patients.
    Takigawa N; Segawa Y; Maeda Y; Takata I; Fujimoto N
    Lung Cancer; 1997 Jul; 17(2-3):211-8. PubMed ID: 9237156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum hepatocyte growth factor/scatter factor levels in inflammatory lung disease.
    Maeda J; Ueki N; Hada T; Higashino K
    Am J Respir Crit Care Med; 1995 Nov; 152(5 Pt 1):1587-91. PubMed ID: 7582299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYFRA 21-1 enzyme-linked immunosorbent assay. Evaluation as a tumor marker in non-small cell lung cancer.
    Lai RS; Hsu HK; Lu JY; Ger LP; Lai NS
    Chest; 1996 Apr; 109(4):995-1000. PubMed ID: 8635383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme-linked immunosorbent assay of pro-gastrin-releasing peptide for small cell lung cancer patients in comparison with neuron-specific enolase measurement.
    Yamaguchi K; Aoyagi K; Urakami K; Fukutani T; Maki N; Yamamoto S; Otsubo K; Miyake Y; Kodama T
    Jpn J Cancer Res; 1995 Jul; 86(7):698-705. PubMed ID: 7559089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum neuron-specific enolase is a useful tumor marker for small cell lung cancer.
    Burghuber OC; Worofka B; Schernthaner G; Vetter N; Neumann M; Dudczak R; Kuzmits R
    Cancer; 1990 Mar; 65(6):1386-90. PubMed ID: 2155054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of tumour and inflammatory markers in lung cancer.
    Oremek GM; Sauer-Eppel H; Bruzdziak TH
    Anticancer Res; 2007; 27(4A):1911-5. PubMed ID: 17649794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of a multiple biomarker assay in patients with lung cancer. A study with logistic regression analysis.
    Lombardi C; Tassi GF; Pizzocolo G; Donato F
    Chest; 1990 Mar; 97(3):639-44. PubMed ID: 1689630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haptoglobin alpha-subunit and hepatocyte growth factor can potentially serve as serum tumor biomarkers in small cell lung cancer.
    Bharti A; Ma PC; Maulik G; Singh R; Khan E; Skarin AT; Salgia R
    Anticancer Res; 2004; 24(2C):1031-8. PubMed ID: 15154618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of hepatocyte growth factor/scatter factor in patients with liver metastases from breast cancer.
    Eichbaum MH; de Rossi TM; Kaul S; Bruckner T; Schneeweiss A; Sohn C
    Tumour Biol; 2007; 28(1):36-44. PubMed ID: 17143015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and serologic markers of stage and prognosis in small cell lung cancer. A multivariate analysis.
    Gronowitz JS; Bergström R; Nôu E; Påhlman S; Brodin O; Nilsson S; Källander CF
    Cancer; 1990 Aug; 66(4):722-32. PubMed ID: 2167141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Tc-99m sestamibi, serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy in small cell lung cancer.
    Lim SC; Park KO; Kim YC; Na KJ; Song H; Bom HS
    Cancer Biother Radiopharm; 2000 Aug; 15(4):381-6. PubMed ID: 11041023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of serum p53 protein in patients with small cell lung cancer and results of its clinicopathological evaluation.
    Segawa Y; Takigawa N; Mandai K; Maeda Y; Takata I; Fujimoto N; Jinno K
    Lung Cancer; 1997 Mar; 16(2-3):229-38. PubMed ID: 9152954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor level as a prognostic determinant of small cell lung cancer in Japanese patients.
    Hasegawa Y; Takanashi S; Okudera K; Kumagai M; Hayashi A; Morimoto T; Okumura K
    Intern Med; 2005 Jan; 44(1):26-34. PubMed ID: 15704659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic and prognostic value of ProGRP in lung cancer.
    Nisman B; Biran H; Ramu N; Heching N; Barak V; Peretz T
    Anticancer Res; 2009 Nov; 29(11):4827-32. PubMed ID: 20032442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum biomarkers of non-neuron-endocrine origin in small-cell lung cancer: a 16-year study on carcinoembryonic antigen, tissue polypeptide antigen and lactate dehydrogenase.
    Buccheri G; Ferrigno D;
    Lung Cancer; 2000 Oct; 30(1):37-49. PubMed ID: 11008008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum NSE, CEA, CT, CA 15-3 levels in human lung cancer.
    Nutini S; Cappelli G; Benucci A; Catalani C; Nozzoli F
    Int J Biol Markers; 1990; 5(4):198-202. PubMed ID: 1965544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The diagnostic values of CA242 combining other tumor markers for lung cancer].
    Zhang S; Ma Y; Yang X
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 May; 22(5):271-3. PubMed ID: 11775851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of plasma scatter factor/hepatocyte growth factor levels in patients with metastatic hormone- refractory prostate cancer: results from cancer and leukemia group B 150005/9480.
    Humphrey PA; Halabi S; Picus J; Sanford B; Vogelzang NJ; Small EJ; Kantoff PW
    Clin Genitourin Cancer; 2006 Mar; 4(4):269-74. PubMed ID: 16729910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic and predictive significance of plasma hepatocyte growth factor and carcinoembryonic antigen in non-small lung cancer after surgery.
    Fang MY; Wang SY; Zheng YB; Gong LY; Bao WL; Gu DL; Mao WM
    Eur Rev Med Pharmacol Sci; 2014; 18(3):398-403. PubMed ID: 24563441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): a combined multivariable analysis on data from nine centres.
    Jørgensen LG; Osterlind K; Genollá J; Gomm SA; Hernández JR; Johnson PW; Løber J; Splinter TA; Szturmowicz M
    Br J Cancer; 1996 Aug; 74(3):463-7. PubMed ID: 8695366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.